GR3004912T3 - - Google Patents
Info
- Publication number
- GR3004912T3 GR3004912T3 GR920401262T GR920401262T GR3004912T3 GR 3004912 T3 GR3004912 T3 GR 3004912T3 GR 920401262 T GR920401262 T GR 920401262T GR 920401262 T GR920401262 T GR 920401262T GR 3004912 T3 GR3004912 T3 GR 3004912T3
- Authority
- GR
- Greece
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK503386A DK503386D0 (da) | 1986-10-20 | 1986-10-20 | Peptidpraeparater |
| DK356987A DK356987D0 (OSRAM) | 1987-07-10 | 1987-07-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3004912T3 true GR3004912T3 (OSRAM) | 1993-04-28 |
Family
ID=26067111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR920401262T GR3004912T3 (OSRAM) | 1986-10-20 | 1992-06-11 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5070186A (OSRAM) |
| EP (1) | EP0265213B1 (OSRAM) |
| KR (1) | KR880004819A (OSRAM) |
| CN (1) | CN87107049A (OSRAM) |
| AU (1) | AU616381B2 (OSRAM) |
| CA (1) | CA1316819C (OSRAM) |
| DE (1) | DE3778287D1 (OSRAM) |
| ES (1) | ES2033871T3 (OSRAM) |
| FI (1) | FI86254C (OSRAM) |
| GR (1) | GR3004912T3 (OSRAM) |
| HU (1) | HU201475B (OSRAM) |
| IE (1) | IE60264B1 (OSRAM) |
| IL (1) | IL84203A (OSRAM) |
| NO (1) | NO170754C (OSRAM) |
| NZ (1) | NZ222214A (OSRAM) |
| PH (1) | PH23446A (OSRAM) |
| PT (1) | PT85949B (OSRAM) |
| YU (1) | YU46665B (OSRAM) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5534488A (en) * | 1993-08-13 | 1996-07-09 | Eli Lilly And Company | Insulin formulation |
| YU18596A (sh) * | 1995-03-31 | 1998-07-10 | Eli Lilly And Company | Analogne formulacije monomernog insulina |
| JP2002500196A (ja) * | 1998-01-09 | 2002-01-08 | ノヴォ ノルディスク アクティーゼルスカブ | 安定化させたインスリン組成物 |
| US7678364B2 (en) | 1999-08-25 | 2010-03-16 | Alkermes, Inc. | Particles for inhalation having sustained release properties |
| DE10114178A1 (de) * | 2001-03-23 | 2002-10-10 | Aventis Pharma Gmbh | Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität |
| EP1423079B1 (en) * | 2001-08-27 | 2006-07-19 | Novo Nordisk A/S | A cartridge and a medical delivery system accommodating such a cartridge |
| KR20050090430A (ko) * | 2002-12-31 | 2005-09-13 | 알투스 파마슈티컬스 인코포레이티드 | 인간 성장 호르몬 결정 및 이것의 제조 방법 |
| NZ554885A (en) * | 2002-12-31 | 2009-07-31 | Altus Pharmaceuticals Inc | Complexes of hgh crystals and protamine polymers |
| EP1976551A4 (en) * | 2005-12-23 | 2009-12-30 | Altus Pharmaceuticals Inc | COMPOSITIONS COMPRISING COMPLEX PROTEIN CRYSTALS BY POLYCATIONS AND PROCESSING METHOD THEREOF |
| ES2542146T3 (es) | 2006-07-31 | 2015-07-31 | Novo Nordisk A/S | Insulinas extendidas PEGiladas. |
| RU2524150C2 (ru) | 2006-09-22 | 2014-07-27 | Ново Нордиск А/С | Аналоги инсулина, устойчивые к протеазам |
| WO2008132229A2 (en) * | 2007-04-30 | 2008-11-06 | Novo Nordisk A/S | Highly concentrated insulin solutions and compositions |
| WO2008132224A2 (en) | 2007-04-30 | 2008-11-06 | Novo Nordisk A/S | Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein |
| ES2618073T3 (es) | 2008-03-14 | 2017-06-20 | Novo Nordisk A/S | Análogos de insulina estabilizados frente a proteasas |
| MX2010009850A (es) | 2008-03-18 | 2010-09-30 | Novo Nordisk As | Analogos de insulina acilados y etabilizados contra proteasas. |
| HUE048608T2 (hu) | 2008-10-17 | 2020-08-28 | Sanofi Aventis Deutschland | Egy inzulin és egy GLP-1 agonista kombinációja |
| RU2537239C2 (ru) | 2009-11-13 | 2014-12-27 | Санофи-Авентис Дойчланд Гмбх | Фармацевтическая композиция, включающая агонист glp-1, инсулин и метионин |
| LT2498801T (lt) | 2009-11-13 | 2018-05-10 | Sanofi-Aventis Deutschland Gmbh | Farmacinė kompozicija, apimanti despro36eksendin-4(1-39)-lys6-nh2 ir metioniną |
| CN101912600B (zh) * | 2010-01-11 | 2014-01-29 | 杨国汉 | 改善胰岛素在溶液中稳定性的方法 |
| US8637458B2 (en) * | 2010-05-12 | 2014-01-28 | Biodel Inc. | Insulin with a stable basal release profile |
| AU2011202239C1 (en) | 2010-05-19 | 2017-03-16 | Sanofi | Long-acting formulations of insulins |
| HUE031181T2 (en) | 2010-08-30 | 2017-06-28 | Sanofi Aventis Deutschland | Use of AVE0010 for the manufacture of a medicament for the treatment of type 2 diabetes |
| US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
| RU2650616C2 (ru) | 2011-08-29 | 2018-04-16 | Санофи-Авентис Дойчланд Гмбх | Фармацевтическая комбинация для применения при гликемическом контроле у пациентов с сахарным диабетом 2 типа |
| AR087744A1 (es) | 2011-09-01 | 2014-04-16 | Sanofi Aventis Deutschland | Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa |
| EP2836508B1 (en) | 2012-04-11 | 2016-06-29 | Novo Nordisk A/S | Insulin formulations |
| US9381247B2 (en) * | 2012-04-16 | 2016-07-05 | Biodel Inc. | Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain |
| US9399065B2 (en) | 2012-04-16 | 2016-07-26 | Biodel Inc. | Magnesium compositions for modulating the pharmacokinetics and injection site pain of insulin |
| SG11201506888VA (en) | 2013-04-03 | 2015-09-29 | Sanofi Sa | Treatment of diabetes mellitus by long-acting formulations of insulins |
| KR20160065126A (ko) | 2013-10-07 | 2016-06-08 | 노보 노르디스크 에이/에스 | 인슐린 유사체의 신규한 유도체 |
| FI3229828T3 (fi) | 2014-12-12 | 2023-05-29 | Sanofi Aventis Deutschland | Glargiini-insuliinin/liksisenatidin vakiosuhteinen formulaatio |
| TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患治療 |
| TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患之治療 |
| AU2017378102B2 (en) | 2016-12-16 | 2022-10-13 | Novo Nordisk A/S | Insulin containing pharmaceutical compositions |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2076082A (en) * | 1935-04-08 | 1937-04-06 | Nordisk Insulinlab | Therapeutic product and process |
| US2179384A (en) * | 1937-04-05 | 1939-11-07 | Univ Alberta | Therapeutic composition and process of making it |
| US2190134A (en) * | 1939-06-09 | 1940-02-13 | Norton Co | Grinding machine |
| US2538018A (en) * | 1944-04-04 | 1951-01-16 | Nordisk Insulinlab | Crystalline product of insulin and alkaline protein and process of making it |
| US2474729A (en) * | 1945-01-03 | 1949-06-28 | Rhone Poulenc Sa | Insulin preparations |
| US2801953A (en) * | 1952-02-28 | 1957-08-06 | Hoechst Ag | Process of preparing crystallized insulin preparations |
| US3102077A (en) * | 1953-08-19 | 1963-08-27 | Christensen Henry Marinus | Preparation of insulin containing 2.75 to 8 percent zinc content |
| DK98342C (da) * | 1959-06-16 | 1964-03-31 | Henry Marinus Dr Christensen | Fremgangsmåde til fremstilling af et insulinpræparat til peroral applikation. |
| US3868358A (en) * | 1971-04-30 | 1975-02-25 | Lilly Co Eli | Protamine-insulin product |
| GB1426061A (en) * | 1972-12-28 | 1976-02-25 | Ici Ltd | Polypeptides |
| US3856771A (en) * | 1973-07-16 | 1974-12-24 | Lilly Co Eli | Process for manufacturing alkali metal or ammonium insulin |
| US4196196A (en) * | 1978-06-19 | 1980-04-01 | Tiholiz Ivan C | Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states |
| AU550068B2 (en) * | 1981-03-10 | 1986-02-27 | Novo Nordisk A/S | Zinc insulin stabilized with calcium or magnesium salts |
| US4839341A (en) * | 1984-05-29 | 1989-06-13 | Eli Lilly And Company | Stabilized insulin formulations |
| US4764592A (en) * | 1987-04-23 | 1988-08-16 | Eli Lilly And Company | Crystalline human proinsulin and process for its production |
-
1987
- 1987-10-14 PH PH35937A patent/PH23446A/en unknown
- 1987-10-19 NO NO874347A patent/NO170754C/no unknown
- 1987-10-19 PT PT85949A patent/PT85949B/pt unknown
- 1987-10-19 IL IL84203A patent/IL84203A/xx not_active IP Right Cessation
- 1987-10-19 DE DE8787309229T patent/DE3778287D1/de not_active Expired - Lifetime
- 1987-10-19 EP EP87309229A patent/EP0265213B1/en not_active Expired - Lifetime
- 1987-10-19 ES ES198787309229T patent/ES2033871T3/es not_active Expired - Lifetime
- 1987-10-19 YU YU191887A patent/YU46665B/sh unknown
- 1987-10-19 AU AU79907/87A patent/AU616381B2/en not_active Ceased
- 1987-10-19 HU HU874683A patent/HU201475B/hu not_active IP Right Cessation
- 1987-10-19 FI FI874596A patent/FI86254C/fi not_active IP Right Cessation
- 1987-10-19 IE IE279987A patent/IE60264B1/en not_active IP Right Cessation
- 1987-10-19 NZ NZ222214A patent/NZ222214A/xx unknown
- 1987-10-20 KR KR870011644A patent/KR880004819A/ko not_active Ceased
- 1987-10-20 CA CA000549713A patent/CA1316819C/en not_active Expired - Fee Related
- 1987-10-20 CN CN198787107049A patent/CN87107049A/zh not_active Withdrawn
-
1989
- 1989-04-19 US US07/340,331 patent/US5070186A/en not_active Expired - Fee Related
-
1992
- 1992-06-11 GR GR920401262T patent/GR3004912T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE872799L (en) | 1988-04-20 |
| AU616381B2 (en) | 1991-10-31 |
| EP0265213A2 (en) | 1988-04-27 |
| NO874347L (no) | 1988-04-21 |
| PT85949B (pt) | 1990-07-31 |
| ES2033871T3 (es) | 1993-04-01 |
| IE60264B1 (en) | 1994-06-29 |
| NO170754B (no) | 1992-08-24 |
| IL84203A (en) | 1993-04-04 |
| PH23446A (en) | 1989-08-07 |
| FI86254B (fi) | 1992-04-30 |
| HU201475B (en) | 1990-11-28 |
| YU46665B (sh) | 1994-01-20 |
| NO170754C (no) | 1992-12-02 |
| US5070186A (en) | 1991-12-03 |
| PT85949A (en) | 1987-11-01 |
| YU191887A (en) | 1989-04-30 |
| FI86254C (fi) | 1992-08-10 |
| EP0265213B1 (en) | 1992-04-15 |
| CN87107049A (zh) | 1988-07-06 |
| AU7990787A (en) | 1988-04-21 |
| DE3778287D1 (de) | 1992-05-21 |
| NZ222214A (en) | 1989-11-28 |
| CA1316819C (en) | 1993-04-27 |
| FI874596L (fi) | 1988-04-21 |
| EP0265213A3 (en) | 1988-11-09 |
| HUT46232A (en) | 1988-10-28 |
| KR880004819A (ko) | 1988-06-27 |
| FI874596A0 (fi) | 1987-10-19 |
| NO874347D0 (no) | 1987-10-19 |